Raltegravir potassium salt ≥98%, crystalline solid

Leverancier: Cayman Chemical
Ratings: (No Reviews)

Total Ratings: 0
Avg. Ratings: 0.0 out of 5

Gevaar

Synoniemen: Raltegravir potassium, Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate

16071-10 16071-1 16071-50 16071-5
CAYM16071-10EA 361 EUR
CAYM16071-10 CAYM16071-1 CAYM16071-50 CAYM16071-5
Raltegravir potassium salt ≥98%, crystalline solid
Raltegravir potassium salt

Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).


It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.

Formule: C₂₀H₂₀FKN₆O₅
MW: 482.51 g/mol
Bewaar temperatuur: Koelkast
MDL Nummer: MFCD12031642
CAS nummer: 871038-72-1

Order Now

Specification Test Results

Purity ≥98%
λmax 210, 312 nm


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Meer About VWR